Methylation determines fibroblast activation and fibrogenesis in the kidney
- PMID: 20418885
- PMCID: PMC3106179
- DOI: 10.1038/nm.2135
Methylation determines fibroblast activation and fibrogenesis in the kidney
Abstract
Fibrogenesis is a pathological wound repair process that fails to cease, even when the initial insult has been removed. Fibroblasts are principal mediators of fibrosis, and fibroblasts from fibrotic tissues fail to return to their quiescent stage, including when cultured in vitro. In a search for underlying molecular mechanisms, we hypothesized that this perpetuation of fibrogenesis is caused by epigenetic modifications. We demonstrate here that hypermethylation of RASAL1, encoding an inhibitor of the Ras oncoprotein, is associated with the perpetuation of fibroblast activation and fibrogenesis in the kidney. RASAL1 hypermethylation is mediated by the methyltransferase Dnmt1 in renal fibrogenesis, and kidney fibrosis is ameliorated in Dnmt1(+/-) heterozygous mice. These studies demonstrate that epigenetic modifications may provide a molecular basis for perpetuated fibroblast activation and fibrogenesis in the kidney.
Conflict of interest statement
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3106179/bin/nihms288522f1.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3106179/bin/nihms288522f2.gif)
![Figure 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3106179/bin/nihms288522f3.gif)
![Figure 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3106179/bin/nihms288522f4.gif)
![Figure 5](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3106179/bin/nihms288522f5.gif)
![Figure 6](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3106179/bin/nihms288522f6.gif)
Comment in
-
Fibrosis under arrest.Nat Med. 2010 May;16(5):523-5. doi: 10.1038/nm0510-523. Nat Med. 2010. PMID: 20448575 Free PMC article.
-
Journal club. Methylation determines fibroblast activation and fibrogenesis in the kidney.Kidney Int. 2010 Sep;78(5):430. Kidney Int. 2010. PMID: 20734473 No abstract available.
References
-
- Eddy AA. Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol. 1996;7:2495–2508. - PubMed
-
- Kuncio GS, Neilson EG, Haverty T. Mechanisms of tubulointerstitial fibrosis. Kidney Int. 1991;39:550–556. - PubMed
-
- Strutz F, Zeisberg M. Renal fibroblasts and myofibroblasts in chronic kidney disease. J Am Soc Nephrol. 2006;17:2992–2998. - PubMed
-
- Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer. 2006;6:392–401. - PubMed
-
- Müller GA, Rodemann HP. Characterization of human renal fibroblasts in health and disease: I. Immunophenotyping of cultured tubular epithelial cells and fibroblasts derived from kidneys with histologically proven interstitial fibrosis. Am J Kidney Dis. 1991;17:680–683. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 DK081576-01A2/DK/NIDDK NIH HHS/United States
- R01 DK030932/DK/NIDDK NIH HHS/United States
- 1K08 CA129204/CA/NCI NIH HHS/United States
- R01 DK081576/DK/NIDDK NIH HHS/United States
- K08 CA129204-03/CA/NCI NIH HHS/United States
- R01CA125550/CA/NCI NIH HHS/United States
- R03 DK081687/DK/NIDDK NIH HHS/United States
- R03 DK081687-02/DK/NIDDK NIH HHS/United States
- R01 CA125550/CA/NCI NIH HHS/United States
- R01 DK055001/DK/NIDDK NIH HHS/United States
- R03DK081687/DK/NIDDK NIH HHS/United States
- R01DK55001/DK/NIDDK NIH HHS/United States
- K08 CA129204/CA/NCI NIH HHS/United States
- K08 DK074558-05/DK/NIDDK NIH HHS/United States
- K08 DK074558/DK/NIDDK NIH HHS/United States
- R01DK081576/DK/NIDDK NIH HHS/United States
- R01DK30932/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases